HEM Pharma Inc. (KOSDAQ:376270)
South Korea · Delayed Price · Currency is KRW 88,400
-5,600 (-5.96%)
At close: Feb 6, 2026
HEM Pharma Market Cap
HEM Pharma has a market cap or net worth of 633.63 billion as of February 6, 2026. Its market cap has increased by 397.33% in one year.
Market Cap
633.63B
Enterprise Value
641.12B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
88,400.00
Market Cap Chart
Since November 5, 2024, HEM Pharma's market cap has increased from 114.18B to 633.63B, an increase of 454.95%. That is a compound annual growth rate of 291.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 633.63B | 93.48% |
| Dec 30, 2025 | 327.49B | 185.09% |
| Dec 30, 2024 | 114.87B | 0.61% |
| Nov 5, 2024 | 114.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HK inno.N | 1.50T |
| G2GBIO | 1.38T |
| Myung In Pharmaceutical LTD. | 927.10B |
| Samyang Biopharm | 743.59B |
| ImmuneOncia Therapeutics | 719.40B |
| CellBion | 327.20B |
| DAE HWA Pharmaceutical | 264.85B |
| NOVAREX | 260.93B |